Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update

Jacques Genest, Jiri Frohlich, George Fodor and Ruth McPherson
CMAJ October 28, 2003 169 (9) 921-924;
Jacques Genest
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiri Frohlich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Fodor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth McPherson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Data supplements


  • Full Guidelines

    Files in this Data Supplement:

    • Full Guidelines [PDF]

  • Corrected PDF

    Files in this Data Supplement:

    • Corrected PDF

Related Articles

  • (2003). Highlights of this issue. CMAJ, 169(9), 897. Accessed March 01, 2021. Retrieved from http://www.cmaj.ca/content/169/9/897.
  • PubMed
  • Google Scholar
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 169 (9)
CMAJ
Vol. 169, Issue 9
28 Oct 2003
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
Jacques Genest, Jiri Frohlich, George Fodor, Ruth McPherson
CMAJ Oct 2003, 169 (9) 921-924;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
Jacques Genest, Jiri Frohlich, George Fodor, Ruth McPherson
CMAJ Oct 2003, 169 (9) 921-924;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Appendix 1
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • PubMed
  • Google Scholar

Cited By...

  • Double-blind randomised controlled trial of the independent and synergistic effect of Spirulina maxima with exercise (ISESE) on general fitness, lipid profile and redox status in overweight and obese subjects: study protocol
  • Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review
  • Quality of Care for First Nations and Non-First Nations People with Diabetes
  • Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy-Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices
  • Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Comprehensive Cardiac Rehabilitation for Secondary Prevention After Transient Ischemic Attack or Mild Stroke: I: Feasibility and Risk Factors
  • A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study
  • Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors
  • Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals
  • Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
  • Re-Evaluating Therapeutic Target Goals for Statin-Treated Patients: Time for Revolutionary Changes?
  • Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
  • Appropriateness of current thresholds for obesity-related measures among Aboriginal people
  • One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk
  • Are patients with hyperlipidemia undertreated?: Study of patients admitted to hospital with coronary events
  • Do Women Have Worse Outcome After Stroke Caused by Intracranial Arterial Stenosis?
  • Lignes directrices canadiennes de 2006 sur la prise en charge et la prevention de l'obesite chez les adultes et les enfants [sommaire]
  • 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]
  • A comprehensive view of sex-specific issues related to cardiovascular disease
  • The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin
  • Risk Equation Determining Unsuccessful Cannulation Events and Failure to Maturation in Arteriovenous Fistulas (REDUCE FTM I)
  • Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
  • Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia
  • Revisiting Rose: strategies for reducing coronary heart disease
  • An evaluation of class effect.
  • Questioning the benefits of statins
  • Questioning the benefits of statins
  • Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia
  • Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations
  • Rebuttal
  • The analysis by Manuel and colleagues creates controversy with headlines, not data
  • The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed
  • Comparison of the Associations of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study
  • Dyslipidemia guidelines
  • Dyslipidemia guidelines
  • Dyslipidemia guidelines
  • Google Scholar

More in this TOC Section

  • Pregnancy, breastfeeding and the SARS-CoV-2 vaccine: an ethics-based framework for shared decision-making
  • The case for relaxing no-visitor policies in hospitals during the ongoing COVID-19 pandemic
  • A “No More Waves” strategy for COVID-19 in Canada
Show more Commentary

Similar Articles

Collections

  • Sections
    • Guidelines
  • Topics
    • Obesity
    • Cardiology: ischemic heart disease

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire